(Q34139774)

31 July 2017

1 reference

title

Olanzapine-associated diabetes mellitus (English)

1 reference

31 July 2017

Elizabeth A Koller

1

1 reference

PubMed ID

12126218

31 July 2017

P Murali Doraiswamy

series ordinal

2

1 reference

PubMed ID

12126218

31 July 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

31 July 2017

1 reference

31 July 2017

22

1 reference

31 July 2017

841-852

1 reference

31 July 2017

7

1 reference

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

31 July 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Use of olanzapine in non-psychotic psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Paediatric uses of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-induced glucose dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-induced acute pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Increasing insulin dose for olanzapine-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Atypical antipsychotic drugs and hyperglycemia in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-lnduced hyperglycemic nonketonic coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Diabetic ketoacidosis associated with olanzapine in an adolescent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Altered ovarian function and cardiovascular risk factors in valproate-treated women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Clozapine-associated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Attitudinal survey of voluntary reporting of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Reporting of adverse drug reactions by hospital doctors and the response to intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Physician Knowledge, Attitudes, and Behavior Related to Reporting Adverse Drug Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

Olanzapine-induced diabetic ketoacidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.841.33629

10.1592/PHCO.22.11.841.33629

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12126218